Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
B-cell Lymphoma 2 (Bcl-2)
100%
Bcl-xL
100%
Mastocytosis
100%
Bone Marrow Lesions
100%
Mast Cells
45%
Adult Patients
18%
Bcl-2 Family Proteins
18%
Immunoblotting
9%
Quantitative PCR
9%
Apoptosis
9%
Healthy Controls
9%
Overexpression
9%
Overexpressing
9%
Pediatric Patients
9%
Immunoreactivity
9%
Rare Diseases
9%
Bone Marrow
9%
Immunohistochemistry
9%
Activating mutation
9%
Cell Culture
9%
Pediatric
9%
Skin Lesions
9%
Cell Apoptosis
9%
Prolonged Survival
9%
Human Mast Cells
9%
In Vivo Activity
9%
Mastocytoma
9%
Cutaneous Lesions
9%
Systemic Mastocytosis
9%
Pediatric Mastocytosis
9%
Cell Culture System
9%
Bcl-2 mRNA
9%
Cutaneous Mastocytosis
9%
Neuroscience
Bcl-2
100%
Mast Cell
75%
Messenger RNA
37%
Pediatrics
37%
Cell Culture
25%
Protein Bcl 2
25%
Programmed Cell Death
25%
In Vitro
12%
Immunohistochemistry
12%
Protein Bcl Xl
12%
Reverse Transcription Polymerase Chain Reaction
12%
Immunoblotting
12%
Immunology and Microbiology
Bcl-2
100%
Mastocytosis
100%
Mast Cell
54%
Cell Culture
18%
Programmed Cell Death
18%
Western Blot
9%
Upregulation
9%
Immunoreactivity
9%
Reverse Transcription Polymerase Chain Reaction
9%
In Vitro
9%